Highlights and Quick Summary
- Annual 5Y Operating CF Growth (CAGR) for 2022 was 0.0% (a NaN% decrease from previous year)
- Annual 5Y Operating CF Growth (CAGR) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 5Y Operating CF Growth (CAGR) for 2020 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 5Y Operating CF Growth (CAGR) of DURECT Corporation
Most recent 5Y Operating CF Growth (CAGR)of DRRX including historical data for past 10 years.Interactive Chart of 5Y Operating CF Growth (CAGR) of DURECT Corporation
DURECT Corporation 5Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 0.0% |
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
| 2016 | – | – | – | – | 0.0% |
| 2015 | – | – | – | – | 0.0% |
| 2014 | – | – | – | – | 0.0% |
| 2013 | – | – | – | – | 0.0% |
| 2012 | – | – | – | – | 0.0% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic